Buhlmann公司是一家瑞士公司，专注于胃肠病学、量子蓝、自身免疫性、细胞过敏、神经免疫学、临床化学、时间生物学、其他免疫分析相关产品的研发、生产、销售。

BÜHLMANN is a fully independent, medium sized and family owned Swiss company. The company was founded in 1976 and has continuously developed over the years. Sister companies have been established in Austria (BÜHLMANN in Austria GmbH) in 1996, in France (BÜHLMANN France SAS) in 2002, in Italy (BUHLMANN Italia srl) in 2009 and Brasil (BÜHLMANN Brasil) in 2013. Since 2005, BÜHLMANN products are directly distributed in Germany.

Buhlmann公司的主要产品包括：

Gastroenterology

Quantum Blue

Autoimmunity

Cellular Allergy

Neuroimmunology

Clinical Chemistry

Chronobiology

Special Products

Other Immunoassays

艾美捷科技代理Protide Pharmaceuticals品牌全系列产品

Protide Pharmaceuticals, Inc.是一家专注于生物制药生产上游工艺的创新型公司。Protide Pharmaceuticals公司的核心产品为血清替代物，其核心价值在于提供高性能、化学成分明确、无动物来源的血清替代物和定制化培养基解决方案，帮助客户大幅减少生物制品生产过程中对胎牛血清或其他动物血清的依赖。，从而提高生物制品生产的效率、一致性、安全性和合规性。

除了血清替代物，Protide Pharmaceuticals公司也提供完整的、优化的无血清培养基配方，专门设计用于支持各种哺乳动物细胞系（如CHO, HEK293, Vero, MRC-5等）在生物反应器中进行高密度培养和高产率生产目标生物分子（如抗体、病毒载体、重组蛋白）。其产品应用于再生医学、肿瘤生物学、细胞生物能量学、肿瘤免疫学、转化医学、表观遗传学，胰岛细胞移植等领域。

▎Protide Pharmaceuticals产品线

● 血清替代品/生物制品生产培养基

Protide Pharmaceuticals的血清替代品通过提供优质、生物一致且功能性的环境，显著改善细胞的生理状态。所有血清替代品均配制成 50 倍浓缩液，这大大降低了成本，并改善了储存和供应链活动。Protide血清替代品不含：酚红、生长因子、类固醇激素、糖皮质激素、细胞粘附分子、生长因子、类固醇激素等物质，可以在其缺失或存在的情况下进行有效研究。细胞分泌的蛋白质可以在不受污染性血清成分干扰的情况下实现高度纯化。

● 低温保护剂

● 细胞处理

● CIT 胰岛细胞溶液

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.